# US 2009/0025095 A1 · Method for Evaluating Compound Using Barlp and Substance for Regulating Eating and Body Weight

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0025095 A1
- Document ID: US20090025095A1
- Status: Published application
- Kind: A1
- Application number: 11/918,099
- Filed: 2006-04-25
- Published: 2009-01-22
- Earliest claimed: 2005-04-26
- Inventors: Hirohide Nambu; Satoshi Ozaki; Takeshi Tanaka; Hisashi Ohta
- Web page: https://patentgrep.com/patent/US20090025095A1

## CPC

- G01N 33/74: involving hormones {or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors}
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 2600/136: Screening for pharmacological compounds
- C12Q 2600/158: Expression markers
- G01N 2333/72: for hormones
- G01N 2500/10: involving cells
- G01N 2800/303: Eating disorders, e.g. anorexia, bulimia
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

It is intended to provide a method for evaluating a compound which regulates eating or body weight characterized by comprising the steps of introducing a BARLP gene and preparing a cell expressing BARLP; bringing a test compound into contact with the cell; and detecting a specific binding of the test compound to the BARLP and a method for evaluating a compound further comprising the step of evaluating a test compound using a nonhuman genetically-engineered animal in which the BARLP gene is inactivated. According to this invention, knowledge about a relationship between BARLP and biological functions is obtained and a method for evaluating a compound targeting BARLP and a BARLP ligand obtained by the evaluation can be provided.

## Claims

### Claim 1

A method for evaluating a compound that regulates eating or body weight, characterized by comprising the steps of:
preparing a cell expressing BARLP by introducing a BARLP gene;
bringing a test compound into contact with the cell; and
detecting a specific binding of the test compound to the BARLP.

### Claim 2

A method for evaluating a compound that regulates eating or body weight, characterized by comprising the steps of:
preparing a cell expressing BARLP by introducing a BARLP gene;
bringing a test compound into contact with the cell;
measuring the activity of an intracellular signal transducer induced by the contact; and
comparing said activity with the activity of the intracellular signal transducer in the absence of contact with the test compound.

### Claim 3

A method for evaluating a compound that regulates eating or body weight, characterized by comprising the steps of:
preparing a cell expressing BARLP by introducing a BARLP gene;
bringing a test compound into contact with the cell;
measuring the expression level of the BARLP or an intracellular signal transducer mediated by the BARLP; and
selecting the test compound which increased or decreased the expression level of the BARLP in comparison with the case in the absence of contact with the test compound.

### Claim 4

(canceled)

### Claim 5

A method for evaluating a compound that regulates eating or body weight, characterized by comprising the steps of:
administering a test compound to a nonhuman genetically modified animal in which a BARLP gene has been inactivated; and
detecting a change in a phenotype of the nonhuman genetically modified animal caused by the administration and comparing a difference with a phenotype of a normal animal.

### Claim 6

A method for evaluating a compound that regulates eating or body weight, characterized by comprising the steps of:
bringing a test compound into contact with BARLP; and
detecting a change in the activity of BARLP caused by the contact.

### Claim 7

(canceled)

### Claim 8

A substance that regulates eating or body weight, characterized by having an action of regulating a function of BARLP.

### Claim 9 (depends on 8)

The substance according to claim 8, characterized in that the substance that regulates eating or body weight is one member selected from the group consisting of natural compounds, organic compounds, inorganic compounds, proteins, peptides, antibodies, antisenses, RNAi and ribozymes.
